POEMs

Patient-Oriented Evidence That Matters

No Cow's Milk Formula for the First Three Days of Life Prevents Food Allergies

 

Am Fam Physician. 2020 Jul 15;102(2):118-119.

Clinical Question

Does cow's milk formula cause more frequent food allergies in newborns at increased risk of atopy?

Bottom Line

In infants at increased risk of atopy, restricting cow's milk supplementation for the first three days of life is associated with a significantly lower risk of developing a cow's milk allergy or food allergies by 24 months of age. (Level of Evidence = 2b)

Synopsis

The study, which took place at a university hospital in Japan, included breastfed newborns at increased risk of atopy (i.e., having a father, mother, or siblings with current or past atopic diseases such as asthma). The newborns were randomized to receive supplementation (if desired) with an amino acid–based elemental formula for at least the first three days of life (n = 156) or with cow's milk formula (n = 156) from the first day of life. When the infants were 24 months of age, the researchers evaluated serum levels of immunoglobulin E (IgE) in response to cow's milk and other specific foods using intention-to-treat analysis. They had follow-up data on all but 10 of the children. Some infants (17%) initially restricted from cow's milk developed an elevated IgE to the cow's milk compared with 32% of the control infants (number needed to treat [NNT] = 7; 95% CI, 5 to 21). Clinical food allergies (2.6% vs. 13.2%; NNT = 10; 95% CI, 6 to 23) and anaphylaxis (0.7% vs. 8.6%; NNT = 13; 95% CI, 8 to 31) were less frequent in the infants initially restricted from cow's milk supplements. The rate of anaphylaxis in the control infants seems higher than expected. Restricting cow's milk supplementation for the first three days of life is a relatively simple and inexpensive intervention. The study's applicability to other populations may be limited.

Study design: Randomized controlled trial (nonblinded)

Funding source: Government

Allocation: Concealed

Setting: Inpatient (any location) with outpatient follow-up

Reference: Urashima M, Mezawa H, Okuyama M, et al. Primary

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, editor-in-chief.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.

 

 

Want to use this article elsewhere? Get Permissions

CME Quiz

More in AFP


Editor's Collections


Related Content


More in Pubmed

MOST RECENT ISSUE


Sep 15, 2020

Access the latest issue of American Family Physician

Read the Issue


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article